Literature DB >> 2146146

Bile acid N-acetylglucosaminides. Formation by microsomal N-acetylglucosaminyltransferases in human liver and kidney.

H Matern1, R Bolz, H U Marschall, J Sjövall, S Matern.   

Abstract

Bile acid N-acetylglucosaminyltransferase activity has been identified in microsomes from human liver and kidney. In both organs the transferases required UDP-N-acetylglucosamine as sugar donor and were mainly active towards ursodeoxycholic acid. Minor activities were observed towards amidated ursodeoxycholic, hyodeoxycholic and beta-muricholic acids. No N-acetylglucosaminidation was detectable with the major primary and secondary bile acids suggesting a specific requirement of the enzymes for bile acids containing 7 beta-or 6 alpha-hydroxyl groups. Kinetic parameters and other catalytic properties of liver and kidney microsomal N-acetylglucosaminyltransferase activities towards ursodeoxycholic acid are described.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2146146     DOI: 10.1016/0014-5793(90)81223-b

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Identification of Two Sulfated Cholesterol Metabolites Found in the Urine of a Patient with Niemann-Pick Disease Type C as Novel Candidate Diagnostic Markers.

Authors:  Masamitsu Maekawa; Kaoru Omura; Shoutaro Sekiguchi; Takashi Iida; Daisuke Saigusa; Hiroaki Yamaguchi; Nariyasu Mano
Journal:  Mass Spectrom (Tokyo)       Date:  2016-11-25

2.  Bile acid N-acetylglucosaminidation. In vivo and in vitro evidence for a selective conjugation reaction of 7 beta-hydroxylated bile acids in humans.

Authors:  H U Marschall; H Matern; H Wietholtz; B Egestad; S Matern; J Sjövall
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

3.  Identification of UDP glycosyltransferase 3A1 as a UDP N-acetylglucosaminyltransferase.

Authors:  Peter I Mackenzie; Anne Rogers; Joanna Treloar; Bo R Jorgensen; John O Miners; Robyn Meech
Journal:  J Biol Chem       Date:  2008-11-03       Impact factor: 5.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.